Ellomay Capital Ltd.

Major Shareholding Notification • Aug 17, 2025

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

Ellomay Capital Ltd

(Name of Issuer)

Ordinary Shares, par value NIS 10.00 per share

(Title of Class of Securities)

M39927120

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

• Rule 13d-1(b)
• Rule 13d-1(c)
• Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. M39927120

1	Names of Reporting Persons
	Clal Insurance Enterprises Holdings Ltd
	Check the appropriate box if a member of a Group (see instructions)
2	(a) (b)
3	Sec Use Only
4	Citizenship or Place of Organization
	ISRAEL
Number of Shares Benefici ally Owned by Each Reporti ng Person With:	5	Sole Voting Power
	6	Shared Voting Power
		1,940,045.00
	7	Sole Dispositive Power
	8	Shared Dispositive Power
		1,940,045.00
9	Aggregate Amount Beneficially Owned by Each Reporting Person
	1,940,045.00
10	Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11	Percent of class represented by amount in row (9)
	14.58 %
12	Type of Reporting Person (See Instructions)
	CO

Comment for Type of Reporting Person: With regard to Rows (6), (8) and (9), please see Item 4. Row (11) is based on 12,852,585 Ordinary Shares issued and outstanding as of June 30, 2025 (as reported by the Issuer in its Prospectus Supplement filed with the Securities and Exchange Commission on July 1, 2025).

SCHEDULE 13G

Item 1.

(a) Name of issuer:

Ellomay Capital Ltd

(b)	Address of issuer's principal executive offices:
	18 Rothschild Boulevard, 1st Floor, Tel Aviv, Israel, 6688112
Item 2.
(a)	Name of person filing:
	Clal Insurance Enterprises Holdings Ltd. ("Clal")
(b)	Address or principal business office or, if none, residence:
	36 Raul Walenberg St., Tel Aviv 66180, Israel
(c)	Citizenship:
	Israel
(d)	Title of class of securities:
	Ordinary Shares, par value NIS 10.00 per share
(e)	CUSIP No.:
	M39927120
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c) (14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item Ownership

4.

(a) Amount beneficially owned:

Of the 1,940,045 Ordinary Shares reported in this Statement as beneficially owned by the Reporting Person, (i) 41,204 Ordinary Shares (which include 34,596 shares issuable upon exercise of warrants to

purchase Ordinary Shares that are exercisable within 60 days) are beneficially held for its own account (the "Nostro Shares"); and (ii) 1,898,841 Ordinary Shares (which include 416,001 shares issuable upon exercise of warrants to purchase Ordinary Shares that are exercisable within 60 days) are held for members of the public through, among others, provident funds and/or pension funds and/or insurance policies, which are managed by subsidiaries of Clal, which subsidiaries operate under independent management and make independent voting and investment decisions. Consequently, this Statement shall not be construed as an admission by Clal, that it is the beneficial owner of more than the Nostro Shares.

(b) Percent of class:

See Row (11) of the cover page of the Reporting Person above.

(c) Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

(ii) Shared power to vote or to direct the vote:

See Row (6) of the cover page of the Reporting Person above and note in Item 4 above.

• (iii) Sole power to dispose or to direct the disposition of:
• (iv) Shared power to dispose or to direct the disposition of:

See Row (8) of the cover page of the Reporting Person above and note in Item 4 above.

Item Ownership of 5 Percent or Less of a Class.

5.

Item Ownership of more than 5 Percent on Behalf of Another Person.

6.

Not Applicable

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8. Identification and Classification of Members of the Group.

Not Applicable

• Item 9. Notice of Dissolution of Group.
  -

Not Applicable

Item Certifications:

10.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Clal Insurance Enterprises Holdings Ltd

Signature:	/s/ Eran Czerninski
Name/Title:	Eran Czerninski/Authorized Signatory
Date:	08/14/2025
Signature:	/s/ Barak Benski
Name/Title:	Barak Benski/Authorized Signatory
Date:	08/14/2025